Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 3
2001 1
2005 2
2007 1
2017 1
2019 1
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy.
Stalin J, Imhof BA, Coquoz O, Jeitziner R, Hammel P, McKee TA, Jemelin S, Poittevin M, Pocard M, Matthes T, Kaci R, Delorenzi M, Rüegg C, Miljkovic-Licina M. Stalin J, et al. Among authors: coquoz o. Cancers (Basel). 2021 Sep 15;13(18):4625. doi: 10.3390/cancers13184625. Cancers (Basel). 2021. PMID: 34572851 Free PMC article.
Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade.
Secondini C, Coquoz O, Spagnuolo L, Spinetti T, Peyvandi S, Ciarloni L, Botta F, Bourquin C, Rüegg C. Secondini C, et al. Among authors: coquoz o. Oncoimmunology. 2017 Apr 20;6(6):e1316437. doi: 10.1080/2162402X.2017.1316437. eCollection 2017. Oncoimmunology. 2017. PMID: 28680747 Free PMC article.
13 results